Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Apartment Investment Management (AIV) PT Lowered to $47 at Canaccord Genuity
-
Canaccord Genuity Starts Okta, Inc (OKTA) at Hold
-
iAnthus Capital Holdings, Inc. Details and Accomplishments in 2016 and Progress in 2017
-
ContraVir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Warrants
-
Divestco Announces Normal Course Issuer Bid and Granting of Stock Options
-
Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights
-
IDEXX Laboratories (IDXX) PT Raised to $180 at Canaccord Genuity
-
Canaccord Genuity Downgrades Thomson Reuters (TRI) to Hold
-
Vermilion Energy Inc. Reports Voting Results of Election of Directors
-
Skyworks Solutions (SWKS) PT Raised to $115 at Canaccord Genuity on 'Strong' Q2 Report; 'IoT Market Driving Growth & Expanding Margins'
-
Marquest 2017-I Mining Super Flow-Through Limited Partnership (National Class and Québec Class) Announces First Closing of Initial Public Offering
-
Cerner (CERN) PT Raised to $66 at Canaccord Genuity Following 1Q
-
Amazon.com (AMZN) PT Raised to $1,150 at Canaccord Genuity
-
Zymeworks (ZYME) IPO Opens 4% Higher
-
Terra Tech Corp. to Present at the 2017 Canaccord Genuity Cannabis Conference on May 10th
-
Vermilion Energy Inc. Announces Results for the Three Months Ended March 31, 2017
-
Canaccord Genuity Starts Snap Inc (SNAP) at Hold
-
Canaccord Genuity Downgrades Columbia Sportswear (COLM) to Hold
-
Zymeworks Announces Pricing of Initial Public Offering
-
Harvest One Announces Closing of Acquisition of ACMPR Licensed Medical Cannabis Producer and Swiss Medical Cannabis-Based Health Products Company
-
Appian Files Registration Statement for Proposed Initial Public Offering
-
ServiceNow (NOW) PT Raised to $110 at Canaccord Genuity Following 1Q Beat
-
Twitter, Inc. (TWTR) PT Raised to $15 at Canaccord Genuity
-
JACKPOTJOY PLC: 2016 Annual Accounts and 2017 Notice of Annual General Meeting
-
Dalradian intersects 1.72 metres at 28.23 g/t gold at Curraghinalt in first results from new drill program
-
Canaccord Genuity Downgrades Panera Bread (PNRA) to Hold
-
NuVasive (NUVA) PT Raised to $84 at Canaccord Genuity; Buy the Weakness
-
AltaGas Ltd. Reports Record 2017 First Quarter Results
-
Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration
-
Canaccord Genuity Announces Stronger Than Expected Outlook for Fourth Quarter Fiscal 2017 Earnings
-
CEVA Inc. (CEVA) PT Raised to $42 at Canaccord Genuity Ahead of 5/4 Quarterly Earnings Report
-
Quidel Corp. (QDEL) PT Raised to $24.50 at Canaccord Genuity; 'Outstanding Q1... Monster Beat'
-
ContraVir Pharma (CTRV) Prices Shares/Warrant Offering at $1
-
ContraVir Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
-
ContraVir Pharma (CTRV) to Offer Common Stock and Warrants
-
ContraVir Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
-
Marquest 2017-I Mining Super Flow-Through Limited Partnership (National Class and Québec Class) Files Final Prospectus
-
Quest Diagnostics (DGX) PT Raised to $115 at Canaccord Genuity Following Strong 1Q Report; 'Continues to Prove Skeptics Wrong... Q1 was a Blowout'
-
Canada's Licensed Producers Gear Up for Recreational Market -- CFN Media
-
Vernalis PLC: FDA Issues a Complete Response Letter on CCP-07 NDA
-
eBay (EBAY) PT Raised to $32 at Canaccord Genuity; Reiterates Hold
-
North American Financial 15 Completes Overnight Offering of $54,110,300
-
The Green Organic Dutchman Holdings Ltd. Closing of $28,350,567 Million Offering
-
Intuitive Surgical (ISRG) PT Raised to $870 at Canaccord Genuity
-
Fogo de Chao (FOGO) PT Raised to $16 at Canaccord Genuity
-
Seabridge Gold Announces Closing of $15.7 Million Bought Deal Public Offering of Common Shares
-
Canaccord Genuity Reiterates Buy Rating and $100 PT on Ultragenyx Pharma (RARE); 'Ph3 Burosumab Meets Primary Endpoint in Adult XLH'
-
BTIG Fixed Income Credit Group Adds Anthony Guido, Steven Jones, Jay Sommer and Jeffrey Walsh
-
TransDigm (TDG): Canaccord Genuity Defends, Says 'Under Review' is Relatively Vague
-
HTG Molecular Diagnostics (HTGM) PT Raised to $6.50 at Canaccord Genuity

